India, June 9 -- In a breakthrough that could pave the way for safer and more precise cancer treatments, scientists from Agharkar Research Institute (ARI), Pune, have developed a next-generation nanomedicine platform capable of silencing key genes that help breast cancer cells survive.

The study, published recently on June 3 in the prestigious journal, Advanced Healthcare Materials, demonstrates how biodegradable nanoparticles can be used to selectively target breast cancer cells and shut down critical genetic pathways responsible for tumour growth and treatment resistance.

The research was carried out by the Nanobioscience group at ARI, an autonomous institute under the department of science and technology (DST), Government of India. T...